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Abstract
Purpose The aim of this study was to evaluate the long-term health-related quality of life (HRQoL) of head and neck cancer
patients with microvascular surgery. Surgical treatment causes great changes in patient HRQoL. Studies focusing on long-term
HRQoL after microvascular reconstruction for head and neck cancer patients are scarce.
Methods We conducted a prospective study of 93 patients with head and neck cancer and microvascular reconstruction in
Helsinki University Hospital Finland. HRQoL was measured using the 15D instrument at baseline and after a mean 4.9-years
follow up. Results were compared with those of an age-standardized general population.
Results Of the 93 patients, 61 (66%) were alive after follow-up; of these, 42 (69%) answered the follow-up questionnaire. The
median time between surgery and HRQoL assessment was 4.9 years (range 3.7–7.8 years). The mean 15D score of all patients
(n = 42) at the 4.9-years follow up was statistically significantly (p = 0.010) and clinically importantly lower than at baseline. The
dimensions of Bspeech^ and Busual activities^ were significantly impaired at the end of follow up. There was a significant
difference at the 4.9-years follow-up in the mean 15D score between patients and the general population (p = 0.014). After follow
up, patients were significantly (p < 0.05) worse off on the dimensions of Bspeech,^ Beating,^ and Busual activities.^
Conclusions Long-term HRQoL was significantly reduced in the whole patient cohort. Speech and usual activities were the most
affected dimensions in head and neck cancer patients with microvascular reconstruction at the end of the 4.9-years follow up.
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Introduction
The incidence of head and neck cancer is increasing in
Finland. In 2015 the incidence of oropharyngeal cancer
in Finland reached approximately 700 cases out of a
population of 5.5 million. Most cases were in men [1].
Malignant tumors in the head and neck area often re-
quire microvascular reconstruction to restore the surgical
defect. Surgery for head and neck cancer and possible
oncological treatments are associated with significant
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physiological and psychological disruption of life due to
physical, esthetic, and functional disability [2].
Health-related quality of life (HRQoL) has become
an important instrument to measure the outcome of head
and neck cancer patients. There are many disease-
specific and generic questionnaires to measure HRQoL
in these populations [3–6]. HRQoL after surgical or on-
cological treatment of head and neck cancers is well
studied. According to previous studies, advanced tu-
mors, extensive surgical resection, free-flap reconstruc-
tion, and postoperative radiotherapy are associated with
low HRQoL [7–9]. Studies focusing on HRQoL after
microvascular reconstruction for head and neck cancers
are scarce. The limitations of these previous studies in-
clude an often short-term follow-up period and variabil-
ity in HRQoL instruments.
The aim of this prospective cohort study was to eval-
uate the long-term HRQoL of head and neck cancer
patients with microvascular reconstruction compared to
an age- and gender-standardized sample of the general
population. HRQoL was measured using the generic 15-
dimensional (15D) instrument, which is a multidimen-
sional generic HRQoL instrument.
Materials and methods
Between December 2008 and February 2013, we con-
ducted a randomized double-blind controlled trial for
patients with head and neck cancer requiring microvas-
cular reconstruction at the Department of Oral and
Maxillofacial Surgery and the Department of Plastic
Surgery, Helsinki University Hospital. Patients with
head and neck cancer who had a microvascular recon-
struction were included in the study and evaluated by
the multidisciplinary head and neck tumor board of the
Helsinki University Hospital. The original purpose of
the study was to evaluate the effects of dexamethasone
on recovery after microvascular surgery. A total of 93
patients were included in the study, 73 from the
Department of Maxillofacial Surgery and 20 from the
Department of Plastic Surgery. Fifty-one patients re-
ceived dexamethasone (DEX) and 42 patients did not
(NON-DEX). A total dose of 60 mg dexamethasone
was administered to 51 patients over 3 days peri- and
postoperatively. A detailed description of the study pro-
tocol and patient characteristics is found in our previous
study [10]. The study was approved by the Research
Ethical Board of Helsinki University Central Hospital,
Finland. Informed consent was obtained from all indi-
vidual participants included in the study before random-
ization. HRQoL was obtained from all patients, despite
randomization.
In this study, HRQoL of the patients was measured
with the multidimensional, generic 15D instrument.
Although there is no consensus for the preferred instru-
ment, the 15D has been used in many cancer patient
groups [11], including those with head and neck cancer
[12, 13]. The 15D compares favorably with other gener-
ic HRQoL instruments such as the NHP, SF-20, SF-6D,
and EQ-5D. A recent study ranked the 15D first among
the most frequently used generic HRQoL instruments in
sensitivity and construct validity in the disease area of
cancer [14]. Using the 15D also enables comparison of
HRQoL results with an age-standardized general popu-
lation. The 15D questionnaire is designed for popula-
tions aged over 15 years.
The 15 dimensions of the instruments are: moving,
seeing, hearing, breathing, sleeping, eating, speech, ex-
cretion, usual activities, mental function, discomfort and
symptoms, depression, distress, vitality, and sexual ac-
tivity. For each dimension, the respondent chooses one
of the five levels that best describe his/her state of
health at the moment (the best level = 1; the worst lev-
el = 5). The 15D can be used as both a profile measure
and a single index score measure. The single index
number (15D score) ranges from 0 (being dead) to 1
(full health). The 15D score is calculated from the
health state descriptive system [15]. A change or differ-
ence of ± 0.015 in the 15D score is considered clinically
important [16–19].
The 15D data for the general population came from
the representative National Health 2011 Survey [20].
For comparison with patients, individuals were selected
from the Helsinki University Hospital catchment area
who were in the age range of the patients (n = 1148).
This sample was weighted to reflect the age and gender
distribution of the patients.
All patients completed the baseline 15D question-
naire before surgery. Follow-up questionnaires were
sent to all patients alive in a prepaid, pre-addressed
enve lope in Oc tobe r 2016 . A l l pa t i en t s who
responded were included in the analysis. The influ-
ence of tumor site, use of free flap, tumor stage, and
postoperative radiation therapy on long-term HRQoL
were investigated. Patient and tumor characteristics
are listed in Table 1.
Statistical analysis
Statistical analysis was performed using SPSS for
Windows statistical software version 22 (SPSS, Inc.,
Chicago, IL, USA). The statistical significance of the
change in the mean dimension and HRQoL scores was
tested by paired samples t test. The groups were
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compared using Chi-square test, independent samples t
test, or ANOVA where appropriate. Two-sided p-values
<0.05 were considered statistically significant.
Results
The median time between surgery and HRQoL assess-
ment was 4.9 years (range 3.7–7.8 years). Of the 93
patients, 61 (66%) were alive by the end of the follow
up (December 2016). A total of 42 (69%) patients an-
swered the long-term follow-up questionnaire (Fig. 1).
All patients were considered as a one group, indepen-
dent of dexamethasone administration. The mean 15D
score of all patients (n = 42) at the 4.9-years follow-up
point (0.844) was statistically significantly (p = 0.010)
and clinically importantly lower than at baseline
(0.881). As shown in Fig. 2, patients perceptions of
Bspeech^ (p < 0.001), Busual activities^ (p < 0.01),
Bmoving^ (p < 0.05) and Bhearing^ (p < 0.05) were
significantly poorer at the end of follow-up. However,
there was some improvement on the psychosocial di-
mensions of Bdiscomfort and symptoms,^ Bdepression,^
and Bdistress,^ although the latter differences were not
statistically significant.
Figure 3 shows the preoperative and Fig. 4 the 4.9-
years postoperative mean dimension scores relative to
the general population. The mean total 15D scores did
not differ statistically significantly at baseline (patients
0.881 vs population 0.906, p = 0.142). However, dimen-
sion scores for Bdepression,^ Bmental,^ and Bdistress^
were lower in the patient cohort group (p < 0.05).
There was a significant difference at the 4.9-years fol-
low up in the mean 15D score between patients and the
general population (patients 0.844 vs population 0.894,
p = 0.014). After the 4.9-years follow up, patients were
significantly (p < 0.05) worse off in the dimensions of
Bspeech,^ Beating,^ and Busual activities.^
The mean 15D score deteriorated in all patients in
the same way regardless of whether or not postoperative
radiotherapy was administered. The type of reconstruc-
tion (ALT, n = 16, 0.807 vs RFA, n = 26, 0.867; p =
0.122), tumor site (maxilla, 0.837, mandible, 0.915,
tongue, 0.865, floor of the mouth, 0.781, tonsillar,
0.773, cheek, 0.866, larynx, 0.671; p = 0.378) and tu-
mor score (T1 + 2, 0.863, T3 + 4A, 0.813; p = 0.241)
had no statistically significant effect on the follow-up
4.9-years mean 15D score (Table 1). Patients with stage
T1–2 tumor (n = 26) were significantly better off on the
dimensions of Busual activities^ (p < 0.05), Bdiscomfort
and symptoms^ (p < 0.01), and Bsexual activity^ (p <
0.05) as compared to those with stage a T3 or T4A
tumor (n = 16) at baseline. The dimension scores of
Busual activities^ and Bhearing^ were significantly
higher in the T1–2 group than in the T3-4A group at
follow up (both p < 0.05). Smokers had a statistically
significantly lower 15D score both at baseline (0.911 vs.
0.827, p = 0.010) and at follow-up (0.890 vs. 0.761;
p < 0.001) than non-smokers; in particular the dimen-
sions of Bspeech^ and Busual activities^ were impaired
at follow-up.
Discussion
In this prospective study, HRQoL was assessed using
the 15D instrument after a 4.9-years follow-up in 42
patients with head and neck cancer and microvascular
reconstruction. The response rate was 69%, which can
be considered good. The primary aim of this study was
to evaluate the long-term HRQoL of head and neck
cancer patients with microvascular reconstruction. The
advantage of the study is the prospective study design
Table 1 Patient and tumor characteristics
Variable All patients (n = 42)
Age (years) 66 (39–88)
Follow-up time (years) 4.9 (3.7–7.8)
Gender
Female/Male 14/28
Smoking (yes/no) 15/27
Reconstruction type
ALT 16
RFA 26
Reconstruction site
Maxilla 8
Mandible 6
Tongue 13
Floor of the mouth 7
Tonsilla 2
Cheek 5
Larynx 1
Tumor type
Epidermoid carcinoma 37
Other 5
T score
T1–2 26
T3-4A 16
Postoperative radiation therapy (yes/no) 17/25
ALT: Anterolateral thigh perforator flap
RFA: Radial forearm flap
Data given as median and range
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in a coherent group of head and neck cancer patients
with a single treatment modality.
The 15D is a widely used HRQoL instrument that
enables comparison between head and neck cancer pa-
tients with free flap and the general population. Several
studies have investigated HRQoL after treatment of oro-
pharyngeal cancer, particularly oncological treatment,
and showed that the 15D is a useful instrument for
evaluation in these patients [12, 13]. Those studies
show that, as expected, a decline in HRQoL is usually
seen during the first 3 months but then HRQoL gradu-
ally improves towards 1 year [21]. Chen et al. noted
that even after almost 5 years after oncological treat-
ment, patients are satisfied with their quality of life
(QoL) [22].
There are surprisingly few studies published on long-
term HRQoL after microvascular reconstruction surgery
of head and neck cancer patients. Pierre et al. showed
in their prospective study of 64 patients that long-term
QoL after oncologic surgery and microvascular free-flap
reconstruction in patients with oral cancer is satisfactory
[8]. Bozec et al. studied long-term QoL and psychoso-
cial outcomes after oropharyngeal cancer surgery and
radial forearm free-flap reconstruction and observed that
long-term QoL was well-preserved [23]. In our study,
the mean 15D score at the 4.9-years follow-up point
was significantly and clinically importantly lower than
at baseline.
Speech problems are common after surgery of head
and neck cancer. The dimensions of Bspeech^ and
Busual activities^ were the most affected dimensions at
the 4.9-years follow-up (p < 0.001). Psychological dis-
tress (swallowing and speech problems, changed appear-
ance, fear of recurrence and death) is common, even
long after treatment in head and neck cancer patients
[24]. Although the differences were not statistically sig-
nificant, in the present study the dimension of
Bdiscomfort and symptoms^ and the psychological
Patients included and who answered the
baseline 15D questionnaire
N=93
Patients who died before
completing 4.9-years follow up
N=32
Patients alive who were sent follow-up
questionnaire
N=61
Patients who answered at 4.9-years 
follow up
N=42
Fig. 1 Patient selection process
Oral Maxillofac Surg (2020) 24:11–1714
dimensions of Bdepression^ and Bdistress^ interestingly
improved during long-term follow up. If any anxiety
occurs during the treatment period or follow-up visits,
patients will have access to psychotherapy in our hos-
pital. This may improve depression and the continuity
of treatment. Regular assessments are beneficial for
mental health.
Large tumors of the head and neck area are associated with
a poor prognosis. Patients with advanced tumor extension
(tumor stage) disease often need more complex resection
and surgery, which affects postoperative HRQoL more than
the treatment of those with early-stage disease [25]. Some
studies have shown that advanced tumor stage, oropharyngeal
cancer, and surgery in combination with chemoradiotherapy
impact overall HRQoL negatively compared to early stage,
oral cavity cancer, and surgery only [26, 27]. In our study,
the dimension scores of Busual activities^ and Bhearing^ were
significantly higher in the early-stage T1–2 group than in the
T3-4A group at follow-up (both p < 0.05). Postoperative radi-
ation therapy causes damage to tissues such as the salivary
gland, which can have a major impact on HRQoL [28].
However, postoperative radiation therapy did not impair
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0,70
0,80
0,90
1,00
e ulavleveL
Dimensions
Population
Patients
p=0.142
** * * *** **
* p < 0.05
** p < 0.001
*** p < 0.001
Fig. 3 15D profiles of microvascular reconstruction patients at baseline compared with age- and gender-matched general population
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Follow-up
Mean 15D score
Baseline        0.881
Follow-up      0.844
p=0.010
* * *** **
* p < 0.05
** p < 0.001
*** p < 0.001
Fig. 2 Mean 15D profiles of head and neck cancer patients with microvascular reconstruction (n = 42) at baseline and 4.9-years after operation
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HRQoL in our patients (p = 0.8) compared with patients who
were treated with surgery only. Although there was no signif-
icant difference in tumor site and long-term HRQoL in our
research, the size of the study is probably not enough to dif-
ferentiate between the different localizations and it would re-
quire a separate broader and possibly a multi-center study.
Although the number of patients in this study was small, the
strength of the study is that it is prospective, thus minimizing
the effect of bias. The follow-up evaluation was conducted
over an extended period (range 3.7–7.8 years) and the re-
sponse rate was good (69%).
Conclusion
We observed in this study that speech and usual activities were
the most affected dimensions in head and neck cancer patients
with microvascular reconstruction at the end of the 4.9-years
follow-up. Long-term HRQoL was significantly reduced in
the whole patient cohort.
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